Page last updated: 2024-08-23

1-deoxynojirimycin and 3-hydroxybutyric acid

1-deoxynojirimycin has been researched along with 3-hydroxybutyric acid in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alberti, KG; Samad, AH; Taylor, R; Ty Willing, TS1
Baek, RC; Bronson, RT; Butters, TD; Denny, CA; Heinecke, KA; Kim, YP; Loh, KS; Platt, FM; Seyfried, TN1

Trials

1 trial(s) available for 1-deoxynojirimycin and 3-hydroxybutyric acid

ArticleYear
Effects of BAYm 1099, new alpha-glucosidase inhibitor, on acute metabolic responses and metabolic control in NIDDM over 1 mo.
    Diabetes care, 1988, Volume: 11, Issue:4

    Topics: 1-Deoxynojirimycin; 3-Hydroxybutyric Acid; Alanine; Blood Glucose; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Eating; Fatty Acids, Nonesterified; Female; Glucosamine; Glycerol; Glycoside Hydrolase Inhibitors; Humans; Hydroxybutyrates; Hypoglycemic Agents; Imino Pyranoses; Insulin; Lactates; Male; Middle Aged; Pyruvates

1988

Other Studies

1 other study(ies) available for 1-deoxynojirimycin and 3-hydroxybutyric acid

ArticleYear
Restricted ketogenic diet enhances the therapeutic action of N-butyldeoxynojirimycin towards brain GM2 accumulation in adult Sandhoff disease mice.
    Journal of neurochemistry, 2010, Volume: 113, Issue:6

    Topics: 1-Deoxynojirimycin; 3-Hydroxybutyric Acid; Analysis of Variance; Animals; beta-N-Acetylhexosaminidases; Blood Glucose; Body Weight; Brain; Chromatography, High Pressure Liquid; Chromatography, Thin Layer; Diet, Ketogenic; Eating; G(M2) Ganglioside; Lipid Metabolism; Mice; Mice, Knockout; Myelin Sheath; Purkinje Cells; Sandhoff Disease

2010